+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Parkinson Drug"

From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
Parkinson's Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Parkinson's Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 159 Pages
  • Global
From
Parkinson's disease - Pipeline Insight, 2024 - Product Thumbnail Image

Parkinson's disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
From
Parkinson's Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Parkinson's Disease: Epidemiology Forecast to 2033

  • Report
  • November 2024
  • 39 Pages
  • Global
From
From
From
Parkinsons Disease Market - Product Thumbnail Image

Parkinsons Disease Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
From
Anticholinergic Drugs Global Market Report 2024 - Product Thumbnail Image

Anticholinergic Drugs Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 898 Pages
  • Global
From
Generic Central Nervous System Drugs Market Report 2025 - Product Thumbnail Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Lewy Body Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • May 2024
  • 60 Pages
  • Global
From
Dyskinesia - Pipeline Insight, 2024 - Product Thumbnail Image

Dyskinesia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life. The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more